BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8649009)

  • 1. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS
    Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract]   [Full Text] [Related]  

  • 4. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 5. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 6. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Graham DY
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of gastroesophageal reflux disease].
    Herszényi L
    Orv Hetil; 2003 Dec; 144(52):2571-3. PubMed ID: 15005067
    [No Abstract]   [Full Text] [Related]  

  • 8. Ebrotidine--a nostrum for ulcer.
    Grover JK; Rathi SS; Vats V
    Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptic ulceration.
    Weir DG
    Br Med J (Clin Res Ed); 1988 Jan; 296(6616):195-200. PubMed ID: 2892567
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach to the patient with unexplained chest pain.
    Katz PO; Codario R; Castell DO
    Compr Ther; 1997 Apr; 23(4):249-53. PubMed ID: 9167916
    [No Abstract]   [Full Text] [Related]  

  • 14. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating gastroesophageal reflux disease.
    Long K; Long R
    Nurse Pract Forum; 1994 Jun; 5(2):63-4. PubMed ID: 7912126
    [No Abstract]   [Full Text] [Related]  

  • 16. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.